Inhibiting the growth hormone (GH)-insulin-like growth factor-1 (IGF-1) signaling pathway by dietary or genetic manipulation extends lifespan in a range of species, including possibly humans. However, achieving this effect pharmacologically has proven difficult. FGF21 is a hormone that is released from the liver in response to fasting and elicits diverse aspects of the adaptive starvation response. Among its metabolic actions in mice, FGF21 causes GH resistance and consequently a marked reduction in circulating IGF-1 concentrations. Remarkably, transgenic mice overexpressing FGF21 from birth live 30-40% longer than wild-type mice. In the studies proposed in this application, we will test whether FGF21 causes a corresponding increase in the healthspan of mice as assessed by measuring strength, immune system and cognitive function. We will further determine whether initiating exposure to FGF21 in adulthood also extends lifespan and healthspan. Lastly, we will test whether FGF21 suppresses the GH-IGF-1 pathway by inducing suppressor of cytokine signaling protein 2, which has well established anti-GH effects. Since several pharmaceutical companies already have FGF21 in clinical trials for treating obesity and type 2 diabetes, FGF21 administration may be a viable approach for extending healthspan and lifespan in humans.
Long-term exposure to the hormone FGF21 dramatically increases lifespan in mice. In the proposed studies, we will determine whether FGF21 causes a corresponding increase in the overall health of the mice, including muscle, immune system and brain health. We will also investigate the molecular mechanism whereby FGF21 increases lifespan.
| Dodd, Garron T; Michael, Natalie J; Lee-Young, Robert S et al. (2018) Insulin regulates POMC neuronal plasticity to control glucose metabolism. Elife 7: |
| Ravussin, Anthony; Youm, Yun-Hee; Sander, Jil et al. (2018) Loss of Nucleobindin-2 Causes Insulin Resistance in Obesity without Impacting Satiety or Adiposity. Cell Rep 24:1085-1092.e6 |
| Crewe, Clair; Joffin, Nolwenn; Rutkowski, Joseph M et al. (2018) An Endothelial-to-Adipocyte Extracellular Vesicle Axis Governed by Metabolic State. Cell 175:695-708.e13 |
| Song, Parkyong; Zechner, Christoph; Hernandez, Genaro et al. (2018) The Hormone FGF21 Stimulates Water Drinking in Response to Ketogenic Diet and Alcohol. Cell Metab 27:1338-1347.e4 |
| Scherer, Philipp E (2018) The many secret lives of adipocytes: implications for diabetes. Diabetologia : |
| Katafuchi, Takeshi; Holland, William L; Kollipara, Rahul K et al. (2018) PPAR?-K107 SUMOylation regulates insulin sensitivity but not adiposity in mice. Proc Natl Acad Sci U S A 115:12102-12111 |
| Kruglikov, Ilja L; Zhang, Zhuzhen; Scherer, Philipp E (2018) The Role of Immature and Mature Adipocytes in Hair Cycling. Trends Endocrinol Metab : |
| Stoiljkovic, Milan; Kelley, Craig; Horvath, Tamas L et al. (2018) Neurophysiological signals as predictive translational biomarkers for Alzheimer's disease treatment: effects of donepezil on neuronal network oscillations in TgF344-AD rats. Alzheimers Res Ther 10:105 |
| Xia, Jonathan Y; Sun, Kai; Hepler, Chelsea et al. (2018) Acute loss of adipose tissue-derived adiponectin triggers immediate metabolic deterioration in mice. Diabetologia 61:932-941 |
| Kusminski, Christine M; Scherer, Philipp E (2018) New zoning laws enforced by glucagon. Proc Natl Acad Sci U S A 115:4308-4310 |
Showing the most recent 10 out of 24 publications
